Stay updated on Pembrolizumab in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Endometrial Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4, indicating a minor site release. There are no changes to the study details or user-facing content evident in this update.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedA platform revision was updated from v3.5.3 to v3.5.4, indicating an underlying update to the site. It does not modify the study information or how the page is used.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page’s footer revision/version indicator changes from **Revision: v3.5.0** to **Revision: v3.5.3**, reflecting an update to the ClinicalTrials.gov site build rather than any study content.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check99 days agoChange DetectedAdded the page revision tag 'Revision: v3.4.3' and removed the previous 'Revision: v3.4.2' tag.SummaryDifference0.1%

- Check120 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Endometrial Cancer Clinical Trial page.